Immunome, Inc. · NASDAQ:IMNM
Higgins Jack sold 13,200 Immunome, Inc. shares (Form 4)
Traded Sep 11, 2026 · Filed Sep 15, 2026
On Sep 11, 2026, Higgins Jack (Chief Scientific Officer) sold 13,200 Immunome, Inc. shares at US$25.32 for US$334K under a trading plan, leaving 56,250 shares. Filed Sep 15, 2026 (Form 4).
- Sold
- 13,200 shares
- Price
- US$25.32
- Value
- US$334K
- Holding after
- 56,250 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | Option exercise | 18,000 | US$1.35 | 78,250 | Direct |
| Sep 11, 2026 | Common Stock | Sale | 13,200 | US$25.32 | 65,050 | Direct |
| Sep 11, 2026 | Common Stock | Gift | 8,800 | 56,250 | Direct |
Source
Related
- Immunome, Inc.
- Higgins Jack
- Immunome, Inc. shareholders
- Form 4 · Higgins Jack · Jul 27, 2026
- Form 4 · Higgins Jack · Apr 3, 2026
- Form 4 · Higgins Jack · Apr 1, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026
- Form 4 · Horn Kinney · Aug 6, 2026